TTD | Drug: D0D7XM

Drug General Information
Drug ID	D0D7XM
Former ID	DIB002150
Drug Name	NC-4016
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 1	[524551]
Company	Nanocarrier
Target and Pathway
Target(s)	Human DNA	Target Info	Inhibitor	[544448]
References
Ref 524551	ClinicalTrials.gov (NCT01999491) A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma. U.S. National Institutes of Health.
Ref 544448	Effects of Treatment with Platinum Azidothymidine and Azidothymidine on Telomerase Activity and Bcl-2 Concentration in Hepatocellular Carcinoma- Induced Rats. Avicenna J Med Biotechnol. 2014 Oct-Dec;6(4): 200-209.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information